In summary, our analysis which originated from the mutations detected in ALS patients, circled back to human patients and investigated whether the proteins that are suggested to play key roles within the ALS protein domain were expressed in the Betz cells, and whether their expression profiles were altered with respect to disease in sALS patients and ALS patients with TDP43 pathology. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.